175 related articles for article (PubMed ID: 21635782)
1. Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation.
Bouloukaki I; Tsiligianni IG; Tsoumakidou M; Mitrouska I; Prokopakis EP; Mavroudi I; Siafakas NM; Tzanakis N
BMC Pulm Med; 2011 Jun; 11():35. PubMed ID: 21635782
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
[TBL] [Abstract][Full Text] [Related]
3. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV
Cane J; Tregidgo L; Thulborn S; Finch D; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2021; 16():1437-1447. PubMed ID: 34093009
[TBL] [Abstract][Full Text] [Related]
5. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
[TBL] [Abstract][Full Text] [Related]
6. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
7. Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease.
Belkowski SM; Boot JD; Mascelli MA; Diamant Z; de Garavilla L; Hertzog B; Polkovitch D; Towers M; Batheja A; D'Andrea MR
Clin Exp Allergy; 2009 Aug; 39(8):1179-86. PubMed ID: 19400896
[TBL] [Abstract][Full Text] [Related]
8. Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.
Meyer M; Bauer RN; Letang BD; Brighton L; Thompson E; Simmen RC; Bonner J; Jaspers I
Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(3):L269-76. PubMed ID: 24285265
[TBL] [Abstract][Full Text] [Related]
9. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
10. Airway and Blood Inflammatory Markers in Waste Collectors.
Raulf M; van Kampen V; Neumann HD; Liebers V; Deckert A; Brüning T; Bünger J; Hoffmeyer F
Adv Exp Med Biol; 2017; 1021():1-14. PubMed ID: 28405893
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
12. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
[TBL] [Abstract][Full Text] [Related]
13. Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.
Bouloukaki I; Tsoumakidou M; Vardavas CI; Mitrouska I; Koutala E; Siafakas NM; Schiza SE; Tzanakis N
Mediators Inflamm; 2009; 2009():812102. PubMed ID: 20182552
[TBL] [Abstract][Full Text] [Related]
14. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
15. Persistence of oxidant and protease burden in the airways after smoking cessation.
Louhelainen N; Rytilä P; Haahtela T; Kinnula VL; Djukanović R
BMC Pulm Med; 2009 May; 9():25. PubMed ID: 19473482
[TBL] [Abstract][Full Text] [Related]
16. Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8.
Henry MT; McMahon K; Costello C; Fitzgerald MX; O'Connor CM
Exp Lung Res; 2002 Mar; 28(2):85-97. PubMed ID: 11868825
[TBL] [Abstract][Full Text] [Related]
17. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
18. Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema.
Betsuyaku T; Takeyabu K; Tanino M; Nishimura M
Eur Respir J; 2002 Jun; 19(6):1051-7. PubMed ID: 12108856
[TBL] [Abstract][Full Text] [Related]
19. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
Westin U; Lundberg E; Wihl JA; Ohlsson K
Allergy; 1999 Aug; 54(8):857-64. PubMed ID: 10485390
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane induces SLPI secretion in the nasal mucosa.
Meyer M; Kesic MJ; Clarke J; Ho E; Simmen RC; Diaz-Sanchez D; Noah TL; Jaspers I
Respir Med; 2013 Mar; 107(3):472-5. PubMed ID: 23195333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
